AmpliPhi Biosciences Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – GlobalData’s summarization of the company’s business strategy. - SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details. - Key manufacturing facilities – A list of key manufacturing facilities of the company. Highlights AmpliPhi Biosciences Corporation (AmpliPhi) formerly Targeted Genetics Corporation is a biotechnology company. It undertakes the development and commercialization of bacteriophage-based antibacterial therapies to treat drug resistant infections. The initial bacteriophage products developed by AmpliPhi have the potential to be formulated and used in a variety of infections such acute and chronic lung infections; skin infections, respiratory diseases; food poisoning; severe diarrhea and other intestinal diseases; burns; wounds; surgical infections and urinary tract infections. AmpliPhi Biosciences Corporation Key Recent Developments Nov 13, 2013: AmpliPhi Biosciences Announces the Appointment of Baxter Phillips, III, as Vice President of Corporate Strategy and Business Development Aug 07, 2013: AmpliPhi Presents Data on Bacteriophages in the Treatment of Lung Infections in Cystic Fibrosis Jul 01, 2013: AmpliPhi Signs Global R&D Agreement with US Army to Develop Bacteriophage Therapies to Treat Resistant Bacterial Infections Feb 04, 2013: AmpliPhi Receives Notice Of Allowance On Key Patent For Its Bacteriophage Therapy From USPTO Reasons to Buy - Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. - Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy. - Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company. - Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance. Note: Some sections may be missing if data is unavailable for the company.